17% placebo) Improvements in cardiometabolic risk factors Safety profile consistent with GLP-1RA class GI side effects were common but led to low discontinuation (4.5%) Conducted across Japan and South Korea Takeaway : Oral semaglutide may offer a potent weight management tool in East Asian patients, where obesity-related risk occurs at lower BMIs. Title : Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes Authors : Takashi Kadowaki, Line Dam Heftdal, Hae-Jin Ko Read the Full Article on JAMA Internal Medicine More posts featuring Yan Leyfman .
A risk study of ASD with typical development indicated significant interaction effects between maternal TT genotype and greater risk for ASD 82 , suggesting MTHFR polymorphism might involve the early development of ASD
Selfishly, I want my mom and grandparents to be around longer, so it's been a huge blessing," she previously told Yahoo
Semaglutide's effect on gut motility can increase the risk of SIBO, leading to symptoms like bloating, constipation, nausea, gas, and diarrhea or even gastroparesis
Genetic factors influencing GLP-1 pathway sensitivity, baseline metabolic health, and comorbidities shape which affordable option will be most effective for you
